Images List Premium Download Classic

Ocular Implant

Ocular Implant-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
November 02, 2017 - N°20170312124

Delivery devices, systems and methods are provided for inserting an implant into an eye. The delivery or inserter devices or systems can be used to dispose or implant an ocular stent or implant, such as a shunt, in communication with the suprachoroidal space, uveal scleral outflow pathway, uveoscleral outflow path or supraciliary space of the eye. The implant can drain ...
Single operator device for delivering an ocular implant
October 12, 2017 - N°20170290705

An ocular implant delivery system is provided with a number of features. In some embodiments, the delivery system comprises a rotation mechanism configured to rotate and orient a cannula of the system, and an advancement mechanism configured to advance and retract an ocular implant through the delivery system and into an eye of a patient. In some embodiments, the cannula ...
Drug eluting ocular implant
Dose Medical Corporation
October 05, 2017 - N°20170281409

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of ...
Ocular Implant Patent Pack
Download + patent application PDFs
Ocular Implant Patent Applications
Download + Ocular Implant-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Ocular Implant-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Ocular implant insertion apparatus and methods
Hoya Corporation
September 14, 2017 - N°20170258582

An exemplary ocular implant insertion system includes a case and a preloaded ocular implant insertion apparatus. The apparatus includes first and second movable structures that move the ocular implant in a predetermined sequence. The respective configurations of the case and the ocular implant insertion apparatus are such that the ocular implant insertion apparatus is not removable from the case when ...
Intra corneal implants and methods of using same
Mag Optics, Ltd.
September 14, 2017 - N°20170258576

The present disclosure provides intra ocular implants and methods of using same to treat various refraction errors in a patient's eye.
Methods and apparatus for treating glaucoma
Mag Optics, Ltd.
September 07, 2017 - N°20170252212

An ocular implant for treating glaucoma is provided, which may include any number of features. More particularly, the present invention relates to implants that facilitate the transfer of fluid from within one area of the eye to another area of the eye. One feature of the implant is that it includes a proximal inlet portion and a distal inlet portion ...
Ocular Implant Patent Pack
Download + patent application PDFs
Ocular Implant Patent Applications
Download + Ocular Implant-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Ocular Implant-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Intraocular implants and related kits and methods
Sight Sciences, Inc.
July 20, 2017 - N°20170202707

Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within schlemm's canal and that may restore or maintain at least partial patency of the canal without substantially interfering with transmural or transluminal fluid flow across the canal. The devices utilize the natural drainage process of the eye and may be implanted ...
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use ...
Allergan, Inc.
June 29, 2017 - N°20170182064

Methods for reducing or preventing transplant rejection in the eye of an individual are described; comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Punctal plug with active agent
Mati Therapeutics Inc.
June 22, 2017 - N°20170172916

A method and apparatus for administering an active agent such as a medicine to a subject, uses an ocular implant such as a punctal plug, to which the active agent has been applied. The implant is installed at the eye of the subject for administering the active agent via tissues of the eye.
Ocular implant delivery device and method
Forsight Vision4, Inc.
June 15, 2017 - N°20170165108

An ocular implant system including an ocular implant sized and shaped to be inserted at least partially into an eye; a carrier member with a shell having a central channel extending at least partially through the shell from a proximal end towards a distal end of the shell. A guide sleeve removably attached within at least a first region of ...
In situ adjustable optical mask
Acufocus, Inc.
June 08, 2017 - N°20170156850

Implantable corneal and intraocular implants such as a mask are provided. The mask can improve the vision of a patient, such as by being configured to increase the depth of focus of an eye of a patient. The mask can include an aperture configured to transmit along an optical axis substantially all visible incident light. The mask can further include ...
Ocular implant delivery system and method
Ivantis, Inc.
June 08, 2017 - N°20170156848

A method and system for deploying an ocular implant into schlemm's canal of an eye. The method includes the steps of inserting a distal end of a cannula through a cornea of the eye and into an anterior chamber of the eye, the cannula having a distal opening extending from the distal end and through a side wall, a curved ...
Process for manufacturing an intraocular lens with an embedded mask
Ivantis, Inc.
May 25, 2017 - N°20170144392

Intraocular implants and methods of making intraocular implants are provided. The intraocular implant can include a mask adapted to increase depth of focus. The method of manufacturing the implant can include positioning the mask with an aperture on a protruding pin of a positioning mold portion. The protruding pin can be configured to center the mask in the intraocular lens.
Ocular Implant Patent Pack
Download + patent application PDFs
Ocular Implant Patent Applications
Download + Ocular Implant-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Ocular Implant-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Masked intraocular implants and lenses
Ivantis, Inc.
May 25, 2017 - N°20170143477

Intraocular implants and methods of making intraocular implants are provided. The intraocular implants can improve the vision of a patient, such as by increasing the depth of focus of an eye of a patient. In particular, the intraocular implants can include a mask having an annular portion with a relatively low visible light transmission surrounding a relatively high transmission central ...
Drug eluting ocular implant with internal plug
Dose Medical Corporation
May 18, 2017 - N°20170135857

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of ...
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
Allergan, Inc.
April 13, 2017 - N°20170100334

Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The ...
Ocular implant container
Novartis Ag
March 23, 2017 - N°20170079839

An implant container for containing an ocular implant is described herein. The implant container can releasably couple to an implant delivery device and provide at least partial alignment of the delivery device with an ocular implant during loading of the ocular implant onto the delivery device.
Hypotensive lipid-containing biodegradable intraocular implants and related implants
Allergan, Inc.
March 09, 2017 - N°20170065612

Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat ...
Prostamide-containing intraocular implants and methods of use thereof
Allergan, Inc.
March 02, 2017 - N°20170056412

Prostamide-containing intraocular implants that biodegrade in the eye and that are effective for reducing intraocular pressure in an eye for a sustained period. The implants generally contain a prostamide, such as bimatoprost, and at least three distinct biodegradable polymers selected from polylactide and poly(lactide-co-glycolide) polymers and are optimized for placement in and compatibility with the anterior chamber of the ...
Sustained drug delivery implant
Allergan, Inc.
March 02, 2017 - N°20170056399

Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.
Punctal plug with active agent
Mati Therapeutics Inc.
March 02, 2017 - N°20170056322

A method and apparatus for administering an active agent such as a medicine to a subject, uses an ocular implant such as a punctal plug, to which the active agent has been applied. The implant is installed at the eye of the subject for administering the active agent via tissues of the eye.
Loading